‘It’s very frustrating’: GPs vent as Shingrix shortage drags on
Associate Professor Charlotte Hespe said GPs still had to prioritise patients for rationed doses.
The months-long shortage of the recombinant herpes zoster vaccine Shingrix has continued to frustrate GPs, who are being forced to ration doses and choose which patients to prioritise as high-risk.
Since 1 November, patients aged 65 and over, immunocompromised adults, and Indigenous patients aged 50 and over have been eligible for a free two-dose course of Shingrix on the National Immunisation Program.
